Metabolic adaptations to repeated periods of contraction with reduced blood flow in canine skeletal muscle

BMC Physiology

Volumn 5, Issue , 2005, Pages

  MacInnes, Alan ^a,b   Timmons, James A ^a,b  

^a PFIZER INC   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE MONOPHOSPHATE DEAMINASE; ADENOSINE TRIPHOSPHATE; AMMONIA; CREATINE PHOSPHATE; LACTIC ACID;

AMMONIA FORMATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; GRACILIS MUSCLE; MUSCLE BIOPSY; MUSCLE BLOOD FLOW; MUSCLE CONTRACTION; MUSCLE EXCITATION; MUSCLE METABOLISM; NONHUMAN; OXYGEN CONSUMPTION; SKELETAL MUSCLE; ADAPTATION; ANIMAL; BLOOD FLOW; METABOLISM; PHYSIOLOGY; VASCULARIZATION; VASOCONSTRICTION;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE TRIPHOSPHATE; AMMONIA; ANIMALS; DOGS; FEMALE; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PHOSPHOCREATINE; REGIONAL BLOOD FLOW; VASOCONSTRICTION;

EID: 23944481437     PISSN: 14726793     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6793-5-11     Document Type: Article

References (35)

1. Addison PD, Neligan PC, Ashrafpour H, Khan A, Zhong A, Moses M, Forrest CR, Pang CY: Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 2003, 285(4):H1435-43.
2. Lewis T: Pain in muscular ischemia. (Its relation to anginal pain). Arch Intern Med 1932, 49:713-729.
3. Albers M, Fratezi AC, De Luccia N: Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg 1992, 16(1):54-59.
4. Greenhaff PL, Campbell-O'Sullivan SP, Constantin-Teodosiu D, Poucher SM, Roberts PA, Timmons JA: Metabolic inertia in contracting skeletal muscle: a novel approach for pharmacological intervention in peripheral vascular disease. Br J Clin Pharmacol 2004, 57(3):237-243.
5. Isner JM, Rosenfield K: Redefining the treatment of peripheral artery disease. Role of percutaneous revascularization. Circulation 1993, 88(4 Pt 1):1534-1557.
6. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT: Exercise training for claudication. N Engl J Med 2002, 347(24):1941-1951.
7. Taivassalo T, Fu K, Johns T, Arnold D, Karpati G, Shoubridge EA: Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 1999, 8(6):1047-1052.
8. Timmons JA, Constantin-Teodosiu D, Poucher SM, Greenhaff PL: Acetyl group availability influences phosphocreatine degradation even during intense muscle contraction. J Physiol 2004, 561(Pt 3):851-859.
9. Timmons JA, Gustafsson T, Sundberg CJ, Jansson E, Hultman E, Kaijser L, Chwalbinska-Moneta J, Constantin-Teodosiu D, Macdonald IA, Greenhaff PL: Substrate availability limits human skeletal muscle oxidative ATP regeneration at the onset of ischemic exercise. J Clin Invest 1998, 101(1):79-85.
10. Timmons JA, Poucher SM, Constantin-Teodosiu D, Macdonald IA, Greenhaff PL: Metabolic responses from rest to steady state determine contractile function in ischemic skeletal muscle. Am J Physiol 1997, 273(2 Pt 1):E233-8.
11. Timmons JA, Poucher SM, Constantin-Teodosiu D, Worrall V, Macdonald IA, Greenhaff PL: Increased acetyl group availability enhances contractile function of canine skeletal muscle during ischemia. J Clin Invest 1996, 97(3):879-883.
12. Hiatt WR, Wolfel EE, Regensteiner JG, Brass EP: Skeletal muscle carnitine metabolism in patients with unilateral peripheral arterial disease. J Appl Physiol 1992, 73(1):346-353.
13. Holm J, Bjorntorp P, Schersten T: Metabolic activity in human skeletal muscle. Effect of peripheral arterial insufficiency. Eur J Clin Invest 1972, 2(5):321-325.
14. Kaijser L, Sundberg CJ, Eiken O, Nygren A, Esbjornsson M, Sylven C, Jansson E: Muscle oxidative capacity and work performance after training under local leg ischemia. J Appl Physiol 1990, 69(2):785-787.
15. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP: Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol 1996, 81(2):780-788.
16. Teravainen H, Makitie J: Striated muscle ultrastructure in intermittent claudication. Arch Pathol Lab Med 1977, 101(5):230-235.
17. Addison P, Neligan P, Forrest C, Zhong A, Perri L, Pang CY: Acute adenosine treatment is effective in augmentation of ischemic tolerance in muscle flaps in the pig: an update. Plast Reconstr Surg 2003, 111(2):842-845.
18. Timmons JA, Poucher SM, Constantin-Teodosiu D, Worrall V, MacDonald IA, Greenhaff PL: Metabolic responses of canine gracilis muscle during contraction with partial ischemia. Am J Physiol 1996, 270(3 Pt 1):E400-6.
19. Graham T, Bangsbo J, Saltin B: Skeletal muscle ammonia production and repeated, intense exercise in humans. Can J Physiol Pharmacol 1993, 71(7):484-490.
20. Hogan MC, Gladden LB, Grassi B, Stary CM, Samaja M: Bioenergetics of contracting skeletal muscle after partial reduction of blood flow. J Appl Physiol 1998, 84(6):1882-1888.
21. Hogan MC, Richardson RS, Kurdak SS: Initial fall in skeletal muscle force development during ischemia is related to oxygen availability. J Appl Physiol 1994, 77(5):2380-2384.
22. Katz A, Sahlin K, Henriksson J: Muscle ammonia metabolism during isometric contraction in humans. Am J Physiol 1986, 250(6 Pt 1):C834-40.
23. Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL: Metabolic response of type I and II muscle fibers during repeated bouts of maximal exercise in humans. Am J Physiol 1996, 271(1 Pt 1):E38-43.
24. Op 't Eijnde B, Van Leemputte M, Brouns F, Van Der Vusse GJ, Labarque V, Ramaekers M, Van Schuylenberg R, Verbessem P, Wijnen H, Hespel P: No effects of oral ribose supplementation on repeated maximal exercise and de novo ATP resynthesis. J Appl Physiol 2001, 91(5):2275-2281.
25. Graham TE, Bangsbo J, Gollnick PD, Juel C, Saltin B: Ammonia metabolism during intense dynamic exercise and recovery in humans. Am J Physiol 1990, 259(2 Pt 1):E170-6.
26. Howlett RA, Hogan MC: Dichloroacetate accelerates the fall in intracellular PO2 at onset of contractions in Xenopus single muscle fibers. Am J Physiol Regul Integr Comp Physiol 2003, 284(2):R481-5.
27. Sabina RL, Mahnke-Zizelman DK: Towards an understanding of the functional significance of N-terminal domain divergence in human AMP deaminase isoforms. Pharmacol Ther 2000, 87(2-3):279-283.
28. Rico-Sanz J: Progressive decrease of intramyocellular accumulation of H+ and Pi in human skeletal muscle during repeated isotonic exercise. Am J Physiol Cell Physiol 2003, 284(6):C1490-6.
29. Timmons JA, Gustafsson T, Sundberg CJ, Jansson E, Greenhaff PL: Muscle acetyl group availability is a major determinant of oxygen deficit in humans during submaximal exercise. Am J Physiol 1998, 274(2 Pt 1):E377-80.
30. MacLean DA, Graham TE, Saltin B: Stimulation of muscle ammonia production during exercise following branched-chain amino acid supplementation in humans. J Physiol 1996, 493 (Pt 3):909-922.
31. Mourtzakis M, Graham TE: Glutamate ingestion and its effects at rest and during exercise in humans. J Appl Physiol 2002, 93(4):1251-1259.
32. Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Hart N: A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol 2000, 36(4):1248-1252.
33. De Ruiter CJ, Van EDEHAANBG, Wevers RA, De Haan A: Muscle function during fatigue in myoadenylate deaminase-deficient Dutch subjects. Clin Sci (Lond) 2000, 98(5):579-585.
34. Norman B, Sabina RL, Jansson E: Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J Appl Physiol 2001, 91(1):258-264.
35. Kasibhatla SR, Bookser BC, Xiao W, Erion MD: AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series. J Med Chem 2001, 44(4):613-618.